Filter
384
Filtered Results: 384
Text search:
pfizer
Featured
Recommendations
45
New Publications
25
Language
Document type
No document type
102
Guidelines
83
Studies & Reports
82
Fact sheets
43
Manuals
23
Strategic & Response Plan
20
Resource Platforms
10
Situation Updates
5
Infographics
5
Training Material
4
Videos
4
Online Courses
3
Countries / Regions
Brazil
18
Global
13
Russia
13
Argentina
10
South Africa
10
Germany
9
Ukraine
8
Latin America and the Carribbean
7
Middle East and North Africa
7
Mozambique
6
Africa
6
Chile
5
India
5
West and Central Africa
4
Western and Central Europe
4
Ecuador
4
Colombia
3
China
3
Senegal
3
Paraguay
3
East and Southern Africa
3
Nepal
2
Kenya
2
El Salvador
2
Nigeria
2
Peru
2
Philippines
2
South–East Asia Region
2
Uganda
2
Eastern Europe
2
Indonesia
2
Liberia
2
Timor Leste/ East Timor
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Syria
1
Iran
1
Congo-Brazzaville
1
Malawi
1
Guinea-Bissau
1
Tanzania
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
United Kingdom
1
Belarus
1
Lebanon
1
Bangladesh
1
Sudan
1
Yemen
1
Angola
1
Chad
1
South Sudan
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
124
Clinical Guidelines
29
Women & Child Health
18
Public Health
10
Key Resources
4
Capacity Building
3
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
184
Mental Health
37
TB
17
HIV
15
NTDs
14
AMR
12
NCDs
9
Refugee
8
Rapid Response
7
Caregiver
6
Global Health Education
6
Disability
5
Health Financing Toolbox
5
Ebola
3
Pharmacy
3
Conflict
3
Planetary Health
2
Specific Hazards
1
Zika
1
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati...
Strategic Plan for COVID-19 vaccination in Argentina
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
SOBRE ESTE GUIA
Este é um guia de referência rápida que resume as recomendações da Superintendência de Atenção Primária (S/SUBPAV/SAP) para o diagnóstico e o manejo na atenção primária da infecção pelo novo coronavírus. O documento representa o posicionamento da S/SUBPAV/SAP e tem a...
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
(Last Update: July 2022)
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
O Informe Semanal de Evidências sobre Variantes de Atenção do SARS-CoV-2 é uma produção organizada pelo Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde (DECIT/SCTIE/MS). O documento tem o objetiv...
Resumen ejecutivo guía de práctica clínica manejo de la infección por Sars-CoV 2
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...
